Jim Simons’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-174,599
Closed -$698K 3368
2025
Q4
$698K Sell
174,599
-135,500
-44% -$753K ﹤0.01% 2442
2025
Q3
$2.62M Buy
+310,099
New +$3.01M ﹤0.01% 1899
2024
Q2
Sell
-80,199
Closed -$2.63M 3616
2024
Q1
$2.63M Buy
+80,199
New +$2.56M ﹤0.01% 1838
2022
Q1
Sell
-126,399
Closed -$3.5M 4167
2021
Q4
$3.5M Sell
126,399
-124,200
-50% -$3.56M ﹤0.01% 1764
2021
Q3
$7.77M Sell
250,599
-145,900
-37% -$3.5M 0.01% 1175
2021
Q2
$8.37M Buy
396,499
+182,800
+86% +$3.66M 0.01% 1306
2021
Q1
$4.32M Buy
213,699
+119,100
+126% +$2.26M 0.01% 1740
2020
Q4
$1.52M Buy
+94,599
New +$1.25M ﹤0.01% 2286
2019
Q2
Sell
-195,499
Closed -$2.46M 3601
2019
Q1
$2.46M Buy
195,499
+109,000
+126% +$1.73M ﹤0.01% 2205
2018
Q4
$1.73M Buy
+86,499
New +$2M ﹤0.01% 2316
2017
Q2
Sell
-90,300
Closed -$2.01M 3233
2017
Q1
$2.01M Buy
90,300
+49,200
+120% +$944K ﹤0.01% 2234
2016
Q4
$608K Sell
41,100
-105,800
-72% -$2.08M ﹤0.01% 2713
2016
Q3
$3.62M Buy
+146,900
New +$3.43M 0.01% 1817
2016
Q2
Sell
-259,100
Closed -$2.74M 3375
2016
Q1
$2.74M Buy
259,100
+118,300
+84% +$1.22M 0.01% 2024
2015
Q4
$1.71M Buy
140,800
+105,300
+297% +$1.55M ﹤0.01% 2209
2015
Q3
$567K Buy
+35,500
New +$693K ﹤0.01% 2583

Other funds holding EVH

Jim Simons's EVH Position: Q1 2026 in Review

Jim Simons sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 174,599 shares — an estimated $698K sold.

Jim Simons first reported a position in EVH in Q3 2015 and held it in 16 quarters. The position peaked at $8.37M in Q2 2021. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Jim Simons reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 174,599 Evolent Health shares in Q1 2026, an estimated $698K.
  • Jim Simons first reported a position in Evolent Health in Q3 2015 and held it in 16 quarters.
  • Jim Simons's Evolent Health position peaked at $8.37M in Q2 2021.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.